MMMário Carlos Araújo Meireles

Mário Carlos Araújo Meireles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mário Carlos Araújo Meireles has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Atividade in vitro de extratos das variedades Arbequina e Picual de Olea europaea L. frente a Candida sp., Microsporum gypseum e Sporothrix brasiliensis

    by Otávia de Almeida Martins, Márcia Kutscher Ripoll, Stefanie Bressan Waller, Luiza da Gama Osório, Angelita dos Reis Gomes, Renata Osório de Faria, João Roberto Braga de Mello, Mário Carlos Araújo Meireles

    A oliveira (Olea europaea L.) é uma planta frutífera, nativa das regiões tropicais e temperadas e uma das mais antigas cultivadas. O uso de extratos vegetais de conhecida atividade antimicrobiana podem adquirir significado nos tratamentos terapêuticos. O objetivo do trabalho é avaliar a atividade antifúngica dos resíduos da indústria de Oliveiras (bagaço) na variedade Picual e de partes vegetativas de cultivares de oliveira (Olea europaea L.) das variedades Arbequina e Picual, frente à Candida spp., Microsporum gypseum e Sporothrix brasiliensis. A metodologia para os testes in vitro foi referenciada pelo documento M27-A3 preconizado pelo CLSI para as leveduras e M38-A2 para fungos filamentosos, adaptados para uso de fitoterápicos. A atividade antifúngica dos extratos hidroalcoólicos de folhas de Olea europaea L. se sobressaíram no resultado final, apresentando ação inibitória nas concentrações de 50 mg/ml, 100 mg/ml e 200 mg/ml, seguido do extrato aquoso de decocção nas mesmas concentrações. Os extratos hidroalcoólicos do bagaço da variedade Picual e das folhas das variedades Picual e Arbequina apresentaram atividade fungistática promissora frente aos isolados de Microsporum gypseum, apresentando CIM que variaram de 100 mg/ml a 200 mg/ml. Os resultados demonstram potencial desses extratos no tratamento da dermatofitose, porém mais estudos devem ser realizados frente as demais espécies de dermatófitos para comprovação de sua efetividade, além de testes de citotoxidade. Os extratos de infusão e hidroalcoólicos das folhas da variedade Picual apresentaram maior ação inibitória frente aos isolados de Candida spp. e Sporothrix brasiliensis apresentando parâmetros importantes para apontar os produtos como uma alternativa terapêutica.


  • Open Access

    Atividade antifúngica in vitro de extratos aquosos do bagaço da Oliveira (Olea europaea L.) frente a isolados fúngicos causadores de candidíase, dermatofitose e esporotricose em humanos e animais

    by Márcia Kutscher Ripoll, Otávia de Almeida Martins, Stefanie Bressan Waller, Anna Luiza Silva, Renata Osório de Faria, Angelita dos Reis Gomes, Tony Picoli, Mário Carlos Araújo Meireles, Tanize dos Santos Acunha, Fabio Clasen Chaves, et al.

    As infecções fúngicas tem se tornado cada vez mais frequentes nos últimos anos. Destacam-se as dermatofitoses, esporotricoses e candidoses. Em função da resistência aos fármacos disponíveis e tendo em vista diversificar o âmbito farmacêutico, realizou-se o estudo a partir do bagaço de O. europaea. Estudos relacionados à oliveira não abordam o bagaço que representa potencial alternativa econômica devido a suas toneladas descartadas pela indústria. Objetivo deste trabalho foi avaliar o perfil sensibilidade in vitro de isolados fúngicos frente extratos aquosos de bagaço de O. europeae. Testar toxicidade celular dos extratos utilizados e determinar presença e quantidade dos compostos fenólicos (oleuropeína e hidroxitirosol). Não foi observado atividade antifúngica desses extratos aquosos diante dos isolados de dermatófitos e Sporothrix brasiliensis. Dos isolados de Candida spp. testados para susceptibilidade, dois foram sensíveis ao extrato de decocção do bagaço a partir da concentração 50 mg/ml de DEC 10’. Na toxicidade da decocção do bagaço de oliveira, observou-se concentrações a partir de 12,5 mg/ml permitiram que pelo menos 50% das células MDBK se mantivessem viáveis. As concentrações de 3,13 até 0,78 mg/ml foram seguras, pois ocorreu 100% de viabilidade celular. Dos compostos (CLAE) hidroxitirosol variou a concentração de 8 x10-4 a 34 x10-4 mg/ml em INF 10’ e de 11 x10-4 a 81 x10-4 mg/ml em DEC 10’. Para oleuropeína, os extratos DEC 10’ variaram sua concentração de 87 x10-3 a 7 x10-3 mg/ml, já para INF 10’ os valores foram de 23 x10-3 mg/ml a não detectado em algumas variedades.

  • Open Access

    Chemical and cytotoxic analyses of three varieties of Brazilian propolis (green propolis, jataí propolis and brown propolis) and its anti-Sporothrix brasiliensis in vitro activity

    by C.M. Peter, S.B. Waller, T. Picoli, L.G. Osório, J.L. Zani, M.C.A. Meireles, R.O. Faria, J.R.B. Mello, S.O. Hubner, M. Lima, et al.

    In this study, we described the antifungal activity of three Brazilian propolis extracts: brown, green and from jataí bees against Sporothrix brasiliensis. The extracts were obtained from ethanolic extraction and their chemical composition was determined by high-performance liquid chromatography coupled to mass spectrometry. The cellular toxicity was measured in MDBK (Madin-Darby Bovine Kidney) cells and quantified by the MTT assay (3- (4,5 dimethylthiazol-2yl -2,5-diphenyl-2H bromine tetrazolato). For antifungal activity, the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) were determined by broth microdilution. The results showed that cell toxicity was not observed at lower concentrations (0.097 to 0.39μg/ml) for all extracts in comparison to cell control. Among the chemical compounds identified, caffeic acid, p-coumaric acid, chlorogenic acid, ferulic acid and rutin were quantified. In antifungal activity, green and jataí did not exhibit activity against the isolates (MIC and MFC greater than 0.78mg/ml). However, all isolates of S. brasiliensis were sensitive to brown propolis (MIC of 0.09 to 0.78mg/ml), including the standard strain (PS. brasiliensis isolates and more studies should be undertaken in order to evaluate its promising use in the treatment of sporotrichosis.


  • Open Access

    Chemical composition and cytotoxicity of extracts of marjoram and rosemary and their activity against Sporothrix brasiliensis

    by Stefanie Bressan Waller, Isabel Martins Madrid, Jéssica Fernanda Hoffmann, Tony Picoli, Marlete Brum Cleff, Fábio Clasen Chaves, Renata Osório de Faria, Mário Carlos Araújo Meireles, João Roberto Braga de Mello

    Purpose. Motivated by increasing reports of antifungal resistance in human and animal sporotrichosis, this study evaluated the chemical composition, cytotoxicity and anti-Sporothrix brasiliensis activity of extracts of marjoram (Origanum majorana) and rosemary (Rosmarinus officinalis). Methodology. Ten (INF10) and 60 min (INF60) infusions, a decoction and a hydroalcoholic extract (HAE, 70 %) were prepared from both plants (10 % w/v). The extract composition was analysed by liquid chromatography/mass spectrometry and the cytotoxicity was evaluated using a colorimetric assay in canine and feline kidney cells. Using a broth microdilution assay (CLSI M38-A2) adapted to the extracts, 30 Sporothrix brasiliensis isolates from dogs, cats and humans, and one Sporothrix schenckii were tested. Results/Key findings. The predominant phenolic compounds found in all extracts were 4-hydroxybenzoic acid, caffeic acid and chlorogenic acid. Luteolin was also one of the predominant compounds, but only in the HAE of marjoram. Extracts of marjoram maintained cell viability in concentrations up to 2.5 mg ml−1 for the feline cell line and up to 10 mg ml−1 for the canine cell line, whereas in rosemary, the cell viability for both kidney lines was maintained with concentrations up to 5 mg ml−1. The activity of rosemary extracts was low or absent. Among the marjoram extracts, HAE was highlighted and had fungistatic activity against Sporothrix brasiliensis (MIC5040 mg ml−1), including in all itraconazole-resistant isolates. S. schenckii sensu stricto was sensitive to marjoram extracts (MIC/MFC ≤5 mg ml−1), with the exception of INF10. Conclusion. These findings support the potential usefulness of the HAE of marjoram in the treatment of sporotrichosis.


  • Open Access

    Effects of essential oils of Rosmarinus officinalis Linn. and Origanum vulgare Linn. from different origins on Sporothrix brasiliensis and Sporothrix schenckii complex

    by S.B. Waller, I.M. Madrid, M.B. Cleff, R. Santin, R.A. Freitag, M.C.A. Meireles, J.R.B. Mello

    Rosmarinus officinalis L. (rosemary) and Origanum vulgare L. (oregano) are known to have antimicrobial properties, but studies on sporotrichosis are scarce. This study aimed to evaluate the anti-Sporothrix spp. activity of essential oils from commercial products and oils extracted from aerial parts of these plants and analyze their chemical constituents. S. schenckii complex and S. brasiliensis (n: 25) isolated from humans, cats, dogs, and environmental soil were tested through M27-A3 guidelines of CLSI with modification for phytotherapics. The essential oils of R. officinalis L. were similar for MIC50 and MFC50 ≤2.25mg/mL for extracted oil; and 4.5mg/mL and 9mg/mL, respectively, for commercial oil. Both products showed MIC90 of 18mg/mL and MFC90 of 36mg/mL. In O. vulgare L., the extracted oil had better activity with MIC50 and MFC50 ≤2.25mg/mL, and MIC90 and MFC90 of 4.5mg/mL, whereas the commercial oil showed MIC50 and MFC50 of 9mg/mL and MIC90 18mg/mL, respectively, and MFC90 of 36mg/mL. Through gas chromatography (CG/FID), thymol and α-terpinene were majority for extracted oil of O. vulgare L., and carvacrol and γ-terpinene made up the majority of the commercial oil. Both essential oils of R. officinalis L. showed 1,8-cineole and α-pinene as major. The fungal isolates were susceptible to all tested essential oils, including in itraconazole-resistant S. brasiliensis isolates. The extracted and commercial oils of the plants presented in vitro anti-Sporothrix spp. activity, and they are promising for treatment of sporotrichosis, including in cases refractory to itraconazole. More studies should be performed about toxicity and in vivo efficacy for its safe use.